Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment

Background: Persistent fever after SARS-CoV-2 infection in rituximab-treated patients has been reported. Due to reduced sensitivity in conventional sampling methods and unspecific symptoms in these patients, distinguishing between low-grade viral replication or hyperinflammation is challenging. Anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertesvåg, Nina Urke, Sakkestad, Sunniva Todnem, Zhou, Fan, Hoff, Ingrid, Kristiansen, Trygve, Jonassen, Trygve Müller, Follesø, Elisabeth, Brokstad, Karl Albert, Dyrhovden, Ruben, Mohn, Kristin G.-I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414720/
https://www.ncbi.nlm.nih.gov/pubmed/36016378
http://dx.doi.org/10.3390/v14081757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414720/
https://www.ncbi.nlm.nih.gov/pubmed/36016378
http://dx.doi.org/10.3390/v14081757

Ejemplares similares